Selective peptidomimetic blockers of autoantigen presentation: a novel therapeutic approach to autoimmune disease

Author： Lehmann P.V.P.V.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.3, 2000-03, pp. : 79-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptides as Therapeutic Approach to Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 28, 2010-09 ,pp. : 3158-3172

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders

By  

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3191-3201

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B as a therapeutic target in autoimmune disease

By O’Sullivan Brendan   Thompson Angus   Thomas Ranjeny  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 111-122

Informa Healthcare

Access to resources Recommend Favorite

T-bet as a possible therapeutic target in autoimmune disease

By Weigmann Benno   Neurath Markus F  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 6, 2002-12 ,pp. : 619-622

Informa Healthcare

Access to resources Recommend Favorite

Novel Therapeutic Approaches to Mitochondrial Disease

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 4, 2004-10 ,pp. : 308-313

Bentham Science Publishers

Access to resources Recommend Favorite